Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -5511.43x is 586% below its 1-year average of -803.72x, near the low end of its 1-year range (-5511.43x–-8.95x).
As of the fiscal period ended Sunday, March 31, 2019. 394.53% below its 12-month average of -1114.47x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2019 (2019-03-31): -5511.43x.
INTEREST COVERAGE RATIO
-5511.43x
INTEREST COVERAGE RATIO AVG TTM
-1114.47x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-394.53%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 462 covered companies
CURRENT VS SECTOR MEDIAN
-97533.83%
vs the sector median at left
Cardiol Therapeutics Inc.
Market Cap
$151.58M
Interest Coverage Ratio
-5511.43x
TTM Avg
-1114.47x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$151.12M
Interest Coverage Ratio
-7.96x
TTM Avg
23.57x
3Y Avg
23.57x
5Y Avg
23.57x
Market Cap
$153.40M
Interest Coverage Ratio
-64.93x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$149.34M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$149.15M
Interest Coverage Ratio
-29.32x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$148.36M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$155.86M
Interest Coverage Ratio
-1.03x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$158.12M
Interest Coverage Ratio
N/A
TTM Avg
2247.41x
3Y Avg
1131.54x
5Y Avg
905.57x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardiol Therapeutics Inc. (CRDL) | $151.58M | -5511.43x | -1114.47x | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $151.12M | -7.96x | 23.57x | 23.57x | 23.57x |
| ALX Oncology Holdings Inc. (ALXO)vs › | $153.40M | -64.93x | N/A | N/A | N/A |
| Anavex Life Sciences Corp. (AVXL)vs › | $149.34M | N/A | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $149.15M | -29.32x | N/A | N/A | N/A |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $148.36M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | -5.64x | N/A | N/A | N/A |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | -1.03x | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $158.12M | N/A | 2247.41x | 1131.54x | 905.57x |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.89M | N/A | N/A | N/A | N/A |
Interest Coverage
-5511.4x
Debt/Equity
0.00
Current Ratio
5.55
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2019-03-31 | -5511.43x |
| 2018-12-31 | -11.95x |
| 2018-09-30 | -8.95x |
| 2018-06-30 | -11.55x |
| 2018-03-31 | -28.49x |
| 2017-12-31 | -30.64x |
| 2017-09-30 | -23.04x |
